WaveTec Vision secures $15.9M; EU to apply new hazardous materials regs to medical devices;

> Aliso Viejo, CA-based WaveTec Vision has closed its Series D financing, securing $15.9 million from existing and new investors. The financing was led by existing investor Versant Ventures, with participation from Accuitive Medical Ventures and De Novo Ventures. New investor Gund Investment Corporation also participated in the funding. WaveTec Vision release

> The EU is about to recast its Restriction of Hazardous Substances Directive. The more rigorous regulations, which already applied to electronic devices such as mobile phones, will also include medical devices. Story

> Clal Biotechnology Industries will soon make its first investment through the NIS 225 million ($64.5 million) medical devices investment fund that it is setting up with Israeli institutional investors. The investment will be several million dollars in Pi R Squared Ltd., which is developing a treatment for calcification of coronary valves, a leading cause of heart attacks. Report

> Life sciences technology company Metabolon has more than doubled its workforce in the past 24 months and expects to double it again during the next two years as it diversifies its business. Article

> A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test. Quest Diagnostics-Vermillion release

> MoMelan Technologies, the developer of a device to treat skin disorders by expanding the surface area of skin grafts, has raised $3.5 million, according to the company's top executive. Story

> The handyscope is the first device for mobile skin cancer examinations with the iPhone. This digital handheld dermatoscope allows doctors capturing and saving microscopic pictures of moles using iPhone, handyscope device and corresponding App. FotoFinder Systems release

> Roche Diagnostics Canada has announced the launch of the cobas 8000 modular analyzer series. In parallel with the launch of this latest member of Roche's "cobas" family of laboratory testing platforms, Roche Diagnostics Canada has completed the first North American installation of the cobas 8000 system at BC Biomedical Laboratories. Roche Diagnostics release

And Finally... A pediatrician says she's invented a medical device that promises to take the sting out of painful injections. And it's called "Buzzy Bee." News